"Tarivid" is a pharmaceutical name that is spelled using the Latin alphabet. The word consists of three syllables, pronounced as "tæ-ri-vid". The first syllable is stressed, and it is pronounced with a short "a" sound. The second syllable has an unstressed "i" sound, and the third syllable ends with a "vid" sound, pronounced as "vɪd". The spelling of "Tarivid" is unique to the brand and is used to differentiate it from similar products in the market.
Tarivid is a brand name for a medication that contains the active ingredient ofloxacin. It belongs to the fluoroquinolone class of antibiotics and is primarily prescribed for the treatment of various bacterial infections. This medicine is administered orally in the form of tablets or as an ophthalmic solution for eye infections.
The main mechanism of action of Tarivid is its ability to inhibit the activity of bacterial DNA gyrase, an enzyme responsible for the replication and repair of bacterial DNA. By interfering with this essential process, Tarivid effectively stops the growth and multiplication of susceptible bacteria, thereby aiding the body's natural defenses in combating the infection.
Tarivid is commonly used to treat bacterial infections such as urinary tract infections, respiratory tract infections, genital infections, and gastrointestinal infections caused by susceptible bacteria. It is important to note that this medication should only be used for bacterial infections and is not effective against viral infections.
Like any medication, Tarivid may have potential side effects such as nausea, diarrhea, headache, or skin reactions. It is essential to follow the prescribed dosage and complete the full course of treatment to ensure the successful eradication of the bacterial infection and prevent the development of antibiotic resistance.
Overall, Tarivid is a fluoroquinolone antibiotic that serves as an effective treatment option for various bacterial infections by inhibiting bacterial DNA replication and repair processes.